Literature DB >> 21207210

Secondary abnormalities involving 1q or 13q and poor outcome in high stage Burkitt leukemia/lymphoma cases with 8q24 rearrangement at diagnosis.

Mariana Tavares de Souza1, Hasmik Mkrtchyan2, Rocio Hassan3, Daniela Ribeiro Ney-Garcia1, Alice Maria Boulhosa de Azevedo4, Elaine Sobral da Costa4, Amanda Faria de Figueiredo1, Thomas Liehr2, Eliana Abdelhay1, Maria Luiza Macedo Silva5.   

Abstract

Classical Burkitt lymphoma/leukemia (BL/L) presenting L3 morphology is found in 1% of childhood ALL. Recently, it has been described that secondary abnormalities could influence the prognosis of these patients. However, little information is available on these cytogenetic abnormalities and their prognostic importance in BL/L. Here, we report four new childhood BL/L cases associated with duplication within 1q or 13q, which exhibited a very unfavorable therapeutic response. We performed both classical and molecular cytogenetic analysis by multicolor chromosome banding of the secondary abnormalities involving the long arms of chromosome 1 or 13. These patients were previously treated with BFM-90 protocol. All of them died during or after the initial treatment. Here, for the first time, the exact breakpoints of the derivative chromosomes involved were determined at the cytogenetic level as 1q21 and 13q33 each.

Entities:  

Mesh:

Year:  2011        PMID: 21207210     DOI: 10.1007/s12185-010-0757-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

Review 1.  Cytogenetics of Burkitt's lymphoma-leukaemia: a review.

Authors:  R Berger; A Bernheim
Journal:  IARC Sci Publ       Date:  1985

Review 2.  Molecular biology of Burkitt's lymphoma.

Authors:  J L Hecht; J C Aster
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

3.  State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.

Authors:  Nyla A Heerema; Alain Bernheim; Megan S Lim; A Thomas Look; Laura Pasqualucci; Elizabeth Raetz; Warren G Sanger; Mitchell S Cairo
Journal:  Pediatr Blood Cancer       Date:  2005-10-15       Impact factor: 3.167

Review 4.  Treatment of mature B-ALL and high grade B-NHL in children.

Authors:  Catherine Patte
Journal:  Best Pract Res Clin Haematol       Date:  2002-12       Impact factor: 3.020

Review 5.  Molecular biology and genetics of lymphomas.

Authors:  Elena M Hartmann; German Ott; Andreas Rosenwald
Journal:  Hematol Oncol Clin North Am       Date:  2008-10       Impact factor: 3.722

6.  High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.

Authors:  Saloua Toujani; Philippe Dessen; Nathalie Ithzar; Gisèle Danglot; Catherine Richon; Yegor Vassetzky; Thomas Robert; Vladimir Lazar; Jacques Bosq; Lydie Da Costa; Christine Pérot; Vincent Ribrag; Catherine Patte; Jöelle Wiels; Alain Bernheim
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

7.  An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.

Authors:  Marilu Nelson; Sherrie L Perkins; Bhavana J Dave; Peter F Coccia; Julia A Bridge; Elizabeth R Lyden; Nyla A Heerema; Mark A Lones; Lauren Harrison; Mitchell S Cairo; Warren G Sanger
Journal:  Br J Haematol       Date:  2009-11-04       Impact factor: 6.998

Review 8.  Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature.

Authors:  S M Kornblau; A Goodacre; F Cabanillas
Journal:  Hematol Oncol       Date:  1991 Mar-Apr       Impact factor: 5.271

9.  Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08.

Authors:  Mark A Lones; Warren G Sanger; Michelle M Le Beau; Nyla A Heerema; Richard Sposto; Sherrie L Perkins; Jonathan Buckley; Marshall E Kadin; Carl R Kjeldsberg; Anna Meadows; Stuart Siegel; Jonathan Finlay; Sharon Bergeron; Mitchell S Cairo
Journal:  J Pediatr Hematol Oncol       Date:  2004-03       Impact factor: 1.289

10.  Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Authors:  H A Poirel; M S Cairo; N A Heerema; J Swansbury; A Aupérin; E Launay; W G Sanger; P Talley; S L Perkins; M Raphaël; K McCarthy; R Sposto; M Gerrard; A Bernheim; C Patte
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

View more
  1 in total

1.  Isochromosome 1q in childhood Burkitt lymphoma: the first reported case in Korea.

Authors:  John Hoon Rim; Hyo Sun Kim; Saeam Shin; Seo Jin Park; Jong Rak Choi
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.